Catalogo dei prodotti della ricerca

SPINELLI, FRANCESCA ROMANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.085
EU - Europa 2.620
AS - Asia 2.117
SA - Sud America 181
AF - Africa 86
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.101
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.000
SG - Singapore 1.193
IT - Italia 1.142
CN - Cina 369
SE - Svezia 365
IN - India 356
FI - Finlandia 199
RU - Federazione Russa 193
DE - Germania 147
BR - Brasile 134
GB - Regno Unito 90
IE - Irlanda 84
UA - Ucraina 73
ID - Indonesia 65
CA - Canada 59
AT - Austria 58
TG - Togo 51
BG - Bulgaria 46
FR - Francia 38
NL - Olanda 32
AR - Argentina 29
BE - Belgio 29
HK - Hong Kong 25
RO - Romania 25
CH - Svizzera 17
TR - Turchia 16
MX - Messico 15
ES - Italia 12
KR - Corea 12
PH - Filippine 12
PL - Polonia 12
PK - Pakistan 11
AU - Australia 9
CL - Cile 9
HR - Croazia 9
IL - Israele 9
SA - Arabia Saudita 9
MK - Macedonia 7
ZA - Sudafrica 7
EG - Egitto 6
HU - Ungheria 6
NG - Nigeria 6
CZ - Repubblica Ceca 5
GR - Grecia 5
IQ - Iraq 5
KZ - Kazakistan 5
LT - Lituania 5
JP - Giappone 4
SC - Seychelles 4
AL - Albania 3
DK - Danimarca 3
DZ - Algeria 3
LV - Lettonia 3
OM - Oman 3
PR - Porto Rico 3
RS - Serbia 3
TH - Thailandia 3
VE - Venezuela 3
VN - Vietnam 3
BD - Bangladesh 2
BO - Bolivia 2
BZ - Belize 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
JO - Giordania 2
MA - Marocco 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BW - Botswana 1
CO - Colombia 1
CR - Costa Rica 1
GH - Ghana 1
GL - Groenlandia 1
GT - Guatemala 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LY - Libia 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
SI - Slovenia 1
SN - Senegal 1
TM - Turkmenistan 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.101
Salva come PNG Salva come JPEG
Città #
Fairfield 881
Singapore 568
Chandler 512
Ashburn 437
Rome 417
Woodbridge 390
Seattle 317
Dearborn 287
Houston 281
Wilmington 280
Cambridge 271
Princeton 178
Ann Arbor 166
San Paolo di Civitate 163
Santa Clara 162
Plano 124
Lawrence 118
Millbury 103
Helsinki 92
Beijing 84
Dublin 84
San Diego 81
Boston 68
New York 66
Moscow 65
Jakarta 61
Lomé 51
Milan 49
Andover 46
Sofia 46
Vienna 39
Cosenza 34
Toronto 34
Norwalk 33
Fremont 30
Boardman 29
San Mateo 28
Brussels 27
Nuremberg 25
Falkenstein 24
Falls Church 24
Federal 21
Council Bluffs 20
Jacksonville 20
Mannheim 20
Yubileyny 20
Des Moines 19
Los Angeles 19
Monterotondo 18
Phoenix 18
Southend 18
Florence 17
Hefei 15
Kunming 15
West Jordan 14
Hong Kong 13
Ottawa 13
Nanjing 12
Palermo 12
Shanghai 12
São Paulo 12
Guangzhou 11
London 11
Redwood City 11
Frankfurt am Main 10
Naples 10
Turin 10
Chicago 9
Dallas 9
Stockholm 9
Zurich 9
Amsterdam 8
Bologna 8
Brasília 8
Bühl 8
Frosinone 8
Grafing 8
Jeddah 8
Paris 8
Warsaw 8
Jinan 7
Padova 7
Treviso 7
Washington 7
Bern 6
Budapest 6
Gangbuk-gu 6
Hyderabad 6
Lübeck 6
Mexico City 6
Rio de Janeiro 6
Slavonski Brod 6
Valenza 6
Athens 5
Buenos Aires 5
Edinburgh 5
Ha Kwai Chung 5
Lappeenranta 5
Madrid 5
Montréal 5
Totale 7.391
Salva come PNG Salva come JPEG
Nome #
Reactive arthritis: current treatment challenges and future perspectives 157
Kidney expression of toll like receptors in lupus nephritis: quantification and clinicopathological correlations 136
Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs 133
Alarmin HMGB1 and soluble RAGE as new tools to evaluate the risk stratification in patients with the antiphospholipid syndrome 130
Anti-polysaccharide and anti-diphtheria protective antibodies after 13-valent pneumococcal conjugate vaccination in rheumatoid arthritis patients under immunosuppressive therapy 119
Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study 118
Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients 114
Acute longitudinal myelitis following Cryptococcus laurentii pneumonia in a patient with systemic lupus erythematosus. 111
Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models 110
Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases 110
A monocentric cohort of obstetric seronegative anti-phospholipid syndrome 108
Ultrasonographic Evaluation of Resistive Index and Renal Artery Stenosis in Patients with Anti-phospholipid Syndrome: Two Distinct Mechanisms? 106
Treating lupus patients with antimalarials. analysis of safety profile in a single-center cohort 104
Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement 102
The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: Results from a monocentric cohort 102
Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study 101
ISG15 protects human Tregs from interferon alpha-induced contraction in a cell-intrinsic fashion 97
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13 95
A Multilocus Genetic Study in a Cohort of Italian SLE Patients Confirms the Association with STAT4 Gene and Describes a New Association with HCP5 Gene. 94
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 94
Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus 94
Evaluation of the Patient Acceptable Symptom State (PASS) in Italian Patients Affected by Systemic Lupus Erythematosus: Association with Disease Activity Indices 91
Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature. 90
Autophagy and rheumatoid arthritis: Current knowledges and future perspectives 89
A Focus on the Diagnosis of Early Rheumatoid Arthritis 87
Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment 87
Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus 86
Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab 86
Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadows 86
Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features 85
“Non-criteria antiphospholipid antibodies”: bridging the gap between seropositive and seronegative antiphospholipid syndrome 85
Biological Drug Treatment of Rheumatoid Arthritis and Spondyloarthritis: Effects on QT Interval and QT Dispersion 85
Belimumab decreases autophagy and citrullination in peripheral blood mononuclear cells from patients with systemic lupus erythematosus 85
Genetic factors in systemic lupus erythematosus: Contribution to disease phenotype 84
Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis 84
Effectiveness and safety of baricitinib in rheumatoid arthritis. a monocentric, longitudinal, real-life experience 84
Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort 84
CD44v3 and CD44v6 isoforms on T cells are able to discriminate different disease activity degrees and phenotypes in systemic lupus erythematosus patients 83
The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus 82
Developing new evaluation methods in systemic lupus erythematosus 82
Treatment with gonadotropin releasing hormone agonists in systemic lupus erythematosus patients receiving cyclophosphamide: a long-term follow-up study 82
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 81
Low expression of estrogen receptor β in T lymphocytes and high serum levels of anti-estrogen receptor α antibodies impact disease activity in female patients with systemic lupus erythematosus 81
TLC immunostaining for detection of "antiphospholipid" antibodies 80
Neurocognitive Dysfunction in Systemic Lupus Erythematosus: Association with Antiphospholipid Antibodies, Disease Activity and Chronic Damage 80
Microparticles and autophagy, a new frontier in the understanding of atherosclerosis in rheumatoid arthritis 80
Comprehensive disease control in systemic lupus erythematosus 80
The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid Arthritis 79
TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis 79
Early response to apremilast treatment in psoriatic arthritis: a real-life ultrasonographic follow-up study 79
Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT. 78
OP0204 LUPUS COMPREHENSIVE DISEASE CONTROL IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: APPLICATION OF A NEW INDEX 78
Pregnancy outcome in systemic lupus erythematosus patients. a monocentric cohort analysis 77
The Role of Disease Activity Score 28 in the Evaluation of Articular Involvement in Systemic Lupus Erythematosus. 76
TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development 75
Low incidence of flare and persistent active disease in a cohort of Italian patients with systemic lupus erythematosus: comment on the article by Nikpour et al 73
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica 71
Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio 69
Effect of Therapeutic Inhibition of TNF on Circulating Endothelial Progenitor Cells in Patients with Rheumatoid Arthritis 69
B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus 68
Serum Levels of Asymmetric Dimethylarginine and Apelin as Potential Markers of Vascular Endothelial Dysfunction in Early Rheumatoid Arthritis 67
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases. a message for rheumatologists 67
Fatigue and widespread pain in systemic lupus erythematosus and Sjogren's syndrome: symptoms of inflammatory disease or associated fibromyalgia? 66
Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis. 65
Biological therapies in rheumatic diseases 65
Post-translational modifications in rheumatoid arthritis and atherosclerosis: Focus on citrullination and carbamylation 65
Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study 65
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 65
Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine 65
Five-years drug survival of mycophenolate mofetil therapy in patients with systemic lupus erythematosus. comparison between renal and non-renal involvement 64
Breastfeeding in women affected by systemic lupus erythematosus. rate, duration and associated factors 64
Autophagy hijacking in PBMC From COVID-19 patients results in lymphopenia 63
Effect of Etanercept on anti-carbamylated protein antibodies in patients with rheumatoid arthritis 63
Musculoskeletal ultrasound in monitoring response to apremilast in psoriatic arthritis patients: results from a longitudinal study 63
Premature ovarian failure in patients affected by systemic lupus erythematosus. a cross-sectional study 63
Complementary effects of carbamylated and citrullinated ll37 in autoimmunity and inflammation in systemic lupus erythematosus 63
Ultrasonographic Evaluation of Renal Resistive Index in Patients with Lupus Nephritis: Correlation with Histologic Findings. 63
Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset 62
Native/citrullinated LL37-specific T-cells help autoantibody production in systemic lupus erythematosus 62
Genetic diversity of staphylococcus aureus influences disease phenotype of systemic lupus erythematosus 62
Serial interferon-γ release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents. 61
Decrease of Asymmetric Dimethyl Arginine After Anti-TNF Therapy in Patients with Rheumatoid Arthritis. 61
ADMA and Apelin, two novel biomarkers of endothelial dysfunction in vascular surgery: a preliminary study in carotid atherosclerosis 61
Foreword: Seminars in Research 2014 Joint Experiences in Rheumatology and Dermatology 61
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 61
Comment on. real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway 61
Induction of remission in rheumatoid arthritis: criteria and opportunities 60
Ultrasound evaluation of hand, wrist and foot joint synovitis in systemic lupus erythematosus. 60
Acne indotta da micofenolato mofetile in pazienti affetti da lupus eritematoso sistemico: uno studio retrospettivo. 60
The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus. 60
Can machine learning models support physicians in systemic lupus erythematosus diagnosis. results from a monocentric cohort 59
Safety profile and causes of withdrawal due to adverse events in systemic lupus erythematosus patients treated long-term with cyclosporine A 59
Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus 59
Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus 58
Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients 58
Janus kinases inhibitors for treating patients with rhupus 58
Monitoring Biological Therapies in Psoriatic Arthritis 57
Correction: Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models (PLoS ONE (2018) 13: 12 (e0207926) DOI: 10.1371/journal.pone.0207926) 57
Anti-D4GDI antibodies activate platelets in vitro. a possible link with thrombocytopenia in primary antiphospholipid syndrome 57
Application of ultrasound in the assessment of oligoarticular psoriatic arthritis subset. results from patients treated with apremilast 57
Totale 7.962
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.039
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020376 0 0 0 0 0 0 0 0 161 112 68 35
2020/2021901 58 106 25 27 21 39 42 77 143 170 124 69
2021/20221.913 28 106 172 138 242 112 36 178 124 143 309 325
2022/20232.065 333 489 115 191 213 201 23 150 182 40 100 28
2023/20241.249 77 125 42 64 69 136 52 95 70 229 150 140
2024/20252.713 90 230 207 377 222 297 339 240 711 0 0 0
Totale 11.731